Drug profile · INN
ocrelizumab
OCREVUS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ocrelizumab (OCREVUS) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ocrelizumab
Brand OCREVUS
Route INJECTION
Formulation INJECTABLE
ATC code L04AG08
Originator Hoffmann-La Roche
Frequently asked questions
What is ocrelizumab?
ocrelizumab (OCREVUS) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ocrelizumab?
OCREVUS is a marketed brand name for ocrelizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ocrelizumab?
ocrelizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.